ArticleBMC neurology2018

Seasonal adherence to, and effectiveness of, subcutaneous interferon β-1a administered by RebiSmart® in patients with relapsing multiple sclerosis: results of the 1-year, observational GEPAT-SMART study.

Spyros N Deftereos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.